Complement in multiple sclerosis: its role in disease and potential as a biomarker. (Q37336914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Complement in multiple sclerosis: its role in disease and potential as a biomarker (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

G Ingram

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Hakobyan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N P Robertson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

24 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

128-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

Experimental models of multiple sclerosis

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Clinical concordance in sibling pairs with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

Association between complement regulatory protein factor H and AM34 antigen, detected in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2008.03830.X

B cells and multiple sclerosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Neuroprotection in stroke by complement inhibition and immunoglobulin therapy

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Advances in understanding of pathogenesis of aHUS and HELLP.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barré syndrome.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Refining genetic associations in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Models of multiple sclerosis: new insights into pathophysiology and repair

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Homogeneity of active demyelinating lesions in established multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys; disseminated encephalomyelitis produced in monkeys with their own brain tissue

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

B-cells and humoral immunity in multiple sclerosis. Implications for therapy

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Multiple sclerosis: a complicated picture of autoimmunity.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Risk alleles for multiple sclerosis identified by a genomewide study

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Pathogenesis of axonal and neuronal damage in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Multiple sclerosis: disease biomarkers as indicated by pathophysiology

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Proteome-based plasma biomarkers for Alzheimer's disease

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Revised diagnostic criteria for neuromyelitis optica

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Evidence for humoral autoimmunity in neuromyelitis optica

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement and demyelinating disease: no MAC needed?

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The Role of the Complement System in Innate Immunity

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

A high-density screen for linkage in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement factor H polymorphism and age-related macular degeneration

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement factor H variant increases the risk of age-related macular degeneration

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Murine complement C4 is not required for experimental autoimmune encephalomyelitis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The role of the complement system in ischemia-reperfusion injury

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The role of nitric oxide in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Axonal degeneration and progressive neurologic disability in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Immunopathology of secondary-progressive multiple sclerosis.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement. Second of two parts

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement. First of two parts

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Caspases determine the vulnerability of oligodendrocytes in the ischemic brain

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement components of the innate immune system in health and disease in the CNS.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Sequence determinants of modified cobra venom neurotoxin which induce immune resistance to experimental allergic encephalomyelitis: molecular mechanisms for immunologic action

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Demyelination: the role of reactive oxygen and nitrogen species.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Intrathecal activation of the complement system and disability in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Genomewide scan of multiple sclerosis in Finnish multiplex families

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Role of complement in inflammation and injury in the nervous system

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Expression of complement in the brain: role in health and disease

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Membrane proteins that protect against complement lysis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

The immunogenesis of the multiple sclerosis plaque

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Allele frequencies of the third component of complement (C3) in MS patients

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Inherited deficiencies of the terminal components of human complement

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Experimental allergic encephalomyelitis in cobra venom factor-treated and C4-deficient guinea pigs

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

A full genome search in multiple sclerosis

18 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675242

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis

3 December 2018

1 reference

12 December 2020

Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis

1 reference

12 December 2020

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

12 December 2020

Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation

1 reference

12 December 2020

Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system

1 reference

12 December 2020

Attenuation of experimental autoimmune demyelination in complement-deficient mice

1 reference

12 December 2020

Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice

1 reference

12 December 2020

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

12 December 2020

Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

1 reference

12 December 2020

The pathogenesis and basis for treatment in multiple sclerosis

1 reference

12 December 2020

Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis with cobra venom factor

1 reference

12 December 2020

Prevention of Experimental Allergic Encephalomyelitis with Cobra Venom Factor

1 reference

12 December 2020

Complement factors in multiple sclerosis

1 reference

12 December 2020

Cerebrospinal fluid complement in multiple sclerosis

1 reference

12 December 2020

Cerebrospinal fluid complement proteins in neurological disease

1 reference

12 December 2020

Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis

1 reference

12 December 2020

Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis

1 reference

12 December 2020

Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis

1 reference

12 December 2020

Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats

1 reference

12 December 2020

Cerebrospinal fluid C9 in demyelinating disease

1 reference

12 December 2020

A population-based study of multiple sclerosis in twins

1 reference

12 December 2020

Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex

1 reference

12 December 2020

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

12 December 2020

The role of complement in the pathogenesis of experimental allergic encephalomyelitis

1 reference

12 December 2020

Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis

1 reference

12 December 2020

Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

1 reference

12 December 2020

Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis

1 reference

12 December 2020

Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis

1 reference

12 December 2020

The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury

1 reference

12 December 2020

No evidence for association of multiple sclerosis with the complement factors C6 and C7

1 reference

12 December 2020

DEMONSTRATION OF COMPLEMENT IN SPINAL FLUID IN MULTIPLE SCLEROSIS

1 reference

12 December 2020

Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats

1 reference

12 December 2020

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

12 December 2020

Complement as a biomarker in multiple sclerosis

1 reference

12 December 2020

Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration

1 reference

12 December 2020

10.1111/J.1365-2249.2008.03830.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040603%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PMC publication ID

2675242

0 references

1 reference